Aceas Abivertinib is a late stage drug that has shown positive clinical trial results in non-small cell lung cancer and B-Cell Lymphoma. Abbvie said on Wednesday the U.S. health agency was reviewing the application for the use of Rinvoq in patients with active psoriatic arthritis, a type of inflammatory arthritis. Abbvie said on Wednesday the U.S. health agency was reviewing the application for the use of Rinvoq in patients with active psoriatic arthritis, a type of inflammatory arthritis. Earlier this month, the company announced completion of the Acea Therapeutics acquisition. The drugmaker said it had responded to the U.S. agencys request for additional details on the benefit-risk profile of the drug, adding the FDA would require additional time for a full review of the application.
Rinvoq is a drug that has showed positive in lots of cellular studies.
( z0 drug :name ( z1 name :op "Rinvoq" ) :ARG0-of ( z2 show :ARG1 ( z3 positive ) :ARG1-of ( z4 study :quant ( z5 lot ) :ARG1 ( z6 cell ) ) ) )
(z0 / drug
    :name (z1 / name
              :op1 "Rinvoq")
    :ARG0-of (z2 / show-01
                 :ARG1 (z3 / positive)
                 :ARG1-of (z4 / study-01
                              :quant (z5 / lot)
                              :ARG1 (z6 / cell))))
Rinvoq is a drug that has showed positive in lots of cellular studies .
z1 :op1 0
z0 :name z1
z0 :ARG0-of z2
z2 :ARG1 z3
z4 :ARG1 z6
z4 :quant z5
z2 :ARG1-of z4